(R,R,R)-alpha-tocopherol decreases abundance ISO RGD:1315461 6480464 PLTP mutant form results in decreased abundance of alpha-Tocopherol CTD PMID:16675720 1,2-dichloroethane decreases expression ISO RGD:1315461 6480464 ethylene dichloride results in decreased expression of PLTP mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine increases expression ISO RGD:1315461 6480464 1, 2-Dimethylhydrazine results in increased expression of PLTP mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of PLTP mRNA CTD PMID:25380136 17alpha-ethynylestradiol affects expression ISO RGD:1315461 6480464 Ethinyl Estradiol affects the expression of PLTP mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression ISO RGD:1315461 6480464 Ethinyl Estradiol results in decreased expression of PLTP mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1315461 6480464 Estradiol results in increased expression of PLTP mRNA CTD PMID:19484750 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLTP mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLTP mRNA CTD PMID:32741896 17beta-hydroxy-5alpha-androstan-3-one decreases expression ISO RGD:1315461 6480464 Dihydrotestosterone results in decreased expression of PLTP mRNA CTD PMID:17023530 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1315461 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1315460 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1315461 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:16054899 , PMID:28433925 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PLTP mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PLTP mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1315461 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLTP mRNA CTD PMID:19770486 more ... 2,4,6-tribromophenol increases expression ISO RGD:1315460 6480464 2 more ... CTD PMID:31675489 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1315460 6480464 tetrabromobisphenol A results in increased expression of PLTP protein CTD PMID:31675489 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of PLTP mRNA CTD PMID:28522335 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1315461 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PLTP mRNA more ... CTD PMID:16054899 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1315460 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PLTP mRNA more ... CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of PLTP mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1315460 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PLTP mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:1315461 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PLTP mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:1315461 6480464 Fenretinide results in decreased expression of PLTP mRNA CTD PMID:28973697 acetamide increases expression EXP 6480464 acetamide results in increased expression of PLTP mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO RGD:1315460 6480464 Aflatoxin B1 affects the expression of PLTP protein CTD PMID:20106945 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of PLTP mRNA CTD PMID:33354967 aflatoxin B1 increases expression ISO RGD:1315460 6480464 Aflatoxin B1 results in increased expression of PLTP mRNA CTD PMID:21632981 , PMID:21641981 aflatoxin B1 decreases expression ISO RGD:1315461 6480464 Aflatoxin B1 results in decreased expression of PLTP mRNA CTD PMID:19770486 all-trans-retinoic acid increases expression ISO RGD:1315460 6480464 Tretinoin results in increased expression of PLTP mRNA CTD PMID:16054129 all-trans-retinoic acid decreases expression ISO RGD:1315460 6480464 Tretinoin results in decreased expression of PLTP mRNA CTD PMID:21934132 amiodarone increases expression ISO RGD:1315461 6480464 Amiodarone results in increased expression of PLTP mRNA CTD PMID:24535564 antirheumatic drug decreases expression ISO RGD:1315460 6480464 Antirheumatic Agents results in decreased expression of PLTP mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1315460 6480464 aristolochic acid I results in decreased expression of PLTP mRNA CTD PMID:33212167 arsane affects methylation ISO RGD:1315460 6480464 Arsenic affects the methylation of PLTP gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1315460 6480464 Arsenic affects the methylation of PLTP gene CTD PMID:25304211 arsenous acid decreases expression ISO RGD:1315460 6480464 Arsenic Trioxide results in decreased expression of PLTP mRNA CTD PMID:19128835 atrazine increases expression ISO RGD:1315460 6480464 Atrazine results in increased expression of PLTP mRNA CTD PMID:22378314 benzo[a]pyrene increases expression ISO RGD:1315460 6480464 Benzo(a)pyrene results in increased expression of PLTP mRNA CTD PMID:20106945 more ... benzo[a]pyrene affects methylation ISO RGD:1315460 6480464 Benzo(a)pyrene affects the methylation of PLTP promoter CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:1315460 6480464 Benzo(a)pyrene results in decreased methylation of PLTP 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1315461 6480464 Benzo(a)pyrene results in increased expression of PLTP mRNA CTD PMID:21964900 benzo[a]pyrene diol epoxide I affects expression ISO RGD:1315460 6480464 7 more ... CTD PMID:20382639 bezafibrate decreases activity ISO RGD:1315460 6480464 Bezafibrate results in decreased activity of PLTP protein CTD PMID:12754275 bezafibrate multiple interactions ISO RGD:1315460 6480464 [Bezafibrate results in decreased activity of PLTP protein] affects the reaction [Bezafibrate results in decreased abundance of Fatty Acids, Nonesterified] CTD PMID:12754275 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1315461 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:19850644 , PMID:28433925 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1315461 6480464 Diethylhexyl Phthalate results in increased expression of PLTP mRNA CTD PMID:19245819 , PMID:19850644 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PLTP mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1315460 6480464 bisphenol A results in decreased expression of PLTP protein CTD PMID:31675489 bisphenol A increases expression ISO RGD:1315461 6480464 bisphenol A results in increased expression of PLTP mRNA CTD PMID:30951980 , PMID:32156529 bisphenol A increases expression ISO RGD:1315460 6480464 bisphenol A results in increased expression of PLTP mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO RGD:1315460 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PLTP mRNA CTD PMID:28628672 bisphenol A multiple interactions ISO RGD:1315461 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol F increases expression ISO RGD:1315461 6480464 bisphenol F results in increased expression of PLTP mRNA CTD PMID:30951980 butan-1-ol multiple interactions ISO RGD:1315460 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PLTP mRNA CTD PMID:29432896 butanal increases expression ISO RGD:1315460 6480464 butyraldehyde results in increased expression of PLTP mRNA CTD PMID:26079696 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of PLTP mRNA CTD PMID:19167457 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of PLTP mRNA CTD PMID:25993096 calcitriol decreases expression ISO RGD:1315460 6480464 Calcitriol results in decreased expression of PLTP mRNA CTD PMID:26485663 carbon nanotube decreases expression ISO RGD:1315461 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 chloropicrin increases expression ISO RGD:1315460 6480464 chloropicrin results in increased expression of PLTP mRNA CTD PMID:26352163 cisplatin multiple interactions ISO RGD:1315461 6480464 [Cisplatin co-treated with RELB mutant form] results in decreased expression of PLTP mRNA CTD PMID:23625948 cisplatin increases expression ISO RGD:1315460 6480464 Cisplatin results in increased expression of PLTP mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1315460 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of PLTP mRNA CTD PMID:27392435 clobetasol increases expression ISO RGD:1315461 6480464 Clobetasol results in increased expression of PLTP mRNA CTD PMID:27462272 clofibrate multiple interactions ISO RGD:1315461 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PLTP mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PLTP mRNA] CTD PMID:17585979 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PLTP mRNA CTD PMID:17602206 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of PLTP mRNA CTD PMID:26577399 cytarabine decreases expression ISO RGD:1315460 6480464 Cytarabine results in decreased expression of PLTP mRNA CTD PMID:21198554 decabromodiphenyl ether increases expression ISO RGD:1315460 6480464 decabromobiphenyl ether results in increased expression of PLTP protein CTD PMID:31675489 dexamethasone multiple interactions ISO RGD:1315461 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PLTP mRNA more ... CTD PMID:16054899 dexamethasone multiple interactions ISO RGD:1315460 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PLTP mRNA more ... CTD PMID:28628672 dextran sulfate decreases expression ISO RGD:1315461 6480464 Dextran Sulfate results in decreased expression of PLTP mRNA CTD PMID:35093514 diarsenic trioxide decreases expression ISO RGD:1315460 6480464 Arsenic Trioxide results in decreased expression of PLTP mRNA CTD PMID:19128835 dioxygen multiple interactions ISO RGD:1315461 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLTP mRNA CTD PMID:30529165 diuron decreases expression EXP 6480464 Diuron results in decreased expression of PLTP mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:1315460 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLTP mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:1315460 6480464 entinostat results in increased expression of PLTP mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1315460 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLTP mRNA CTD PMID:27188386 epoxiconazole affects expression ISO RGD:1315461 6480464 epoxiconazole affects the expression of PLTP mRNA CTD PMID:35436446 ethanol multiple interactions ISO RGD:1315460 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PLTP mRNA CTD PMID:29432896 fenofibrate increases expression ISO RGD:1315461 6480464 Fenofibrate results in increased expression of PLTP mRNA CTD PMID:11798191 fenthion increases expression ISO RGD:1315461 6480464 Fenthion results in increased expression of PLTP mRNA CTD PMID:34813904 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of PLTP mRNA CTD PMID:24136188 fumonisin B1 increases expression ISO RGD:1315461 6480464 fumonisin B1 results in increased expression of PLTP mRNA CTD PMID:16221962 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PLTP mRNA CTD PMID:33387578 GW 3965 increases expression ISO RGD:1315460 6480464 GW 3965 results in increased expression of PLTP mRNA CTD PMID:17449538 GW 501516 multiple interactions ISO RGD:1315460 6480464 [GW 501516 binds to PPARD protein] which results in increased expression of PLTP mRNA CTD PMID:16197558 high-density lipoprotein cholesterol affects abundance ISO RGD:1315460 6480464 PLTP protein affects the abundance of Cholesterol, HDL CTD PMID:12754275 indometacin multiple interactions ISO RGD:1315460 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PLTP mRNA more ... CTD PMID:28628672 inulin multiple interactions ISO RGD:1315461 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PLTP mRNA CTD PMID:36331819 isotretinoin increases expression ISO RGD:1315460 6480464 Isotretinoin results in increased expression of PLTP mRNA CTD PMID:20436886 Lasiocarpine decreases expression EXP 6480464 lasiocarpine results in decreased expression of PLTP mRNA CTD PMID:32419051 lipopolysaccharide affects response to substance ISO RGD:1315461 6480464 PLTP affects the susceptibility to Lipopolysaccharides CTD PMID:21787334 metformin decreases expression EXP 6480464 Metformin results in decreased expression of PLTP mRNA CTD PMID:31324951 methidathion increases expression ISO RGD:1315461 6480464 methidathion results in increased expression of PLTP mRNA CTD PMID:34813904 methotrexate affects expression ISO RGD:1315461 6480464 Methotrexate affects the expression of PLTP mRNA CTD PMID:18502557 methotrexate increases expression ISO RGD:1315460 6480464 Methotrexate results in increased expression of PLTP mRNA CTD PMID:17379860 methotrexate decreases expression ISO RGD:1315461 6480464 Methotrexate results in decreased expression of PLTP mRNA CTD PMID:18502557 N-nitrosodiethylamine increases expression ISO RGD:1315461 6480464 Diethylnitrosamine results in increased expression of PLTP mRNA CTD PMID:17854601 N-nitrosodiethylamine multiple interactions ISO RGD:1315461 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of PLTP mRNA] CTD PMID:17854601 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PLTP mRNA CTD PMID:17602206 nickel sulfate decreases expression ISO RGD:1315461 6480464 nickel sulfate results in decreased expression of PLTP mRNA CTD PMID:16100012 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of PLTP mRNA CTD PMID:24136188 obeticholic acid decreases expression ISO RGD:1315460 6480464 obeticholic acid results in decreased expression of PLTP mRNA CTD PMID:27939613 ozone decreases expression ISO RGD:1315461 6480464 Ozone results in decreased expression of PLTP mRNA CTD PMID:12763052 ozone multiple interactions ISO RGD:1315461 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PLTP mRNA CTD PMID:34911549 paracetamol multiple interactions ISO RGD:1315461 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PLTP mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PLTP mRNA] CTD PMID:17585979 paracetamol increases expression ISO RGD:1315460 6480464 Acetaminophen results in increased expression of PLTP mRNA CTD PMID:22230336 paraquat affects expression EXP 6480464 Paraquat affects the expression of PLTP mRNA CTD PMID:15493455 paraquat decreases expression ISO RGD:1315461 6480464 Paraquat results in decreased expression of PLTP mRNA CTD PMID:17215068 perfluorobutyric acid increases expression ISO RGD:1315461 6480464 perfluorobutyric acid results in increased expression of PLTP mRNA CTD PMID:34474067 perfluorohexanesulfonic acid increases expression ISO RGD:1315461 6480464 perfluorohexanesulfonic acid results in increased expression of PLTP mRNA CTD PMID:21705711 perfluorononanoic acid multiple interactions ISO RGD:1315461 6480464 [Dietary Fats co-treated with perfluoro-n-nonanoic acid] results in increased expression of PLTP mRNA CTD PMID:33483757 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1315461 6480464 [Dietary Fats co-treated with perfluorooctane sulfonic acid] results in increased expression of PLTP mRNA more ... CTD PMID:33483757 , PMID:36331819 perfluorooctanoic acid increases expression ISO RGD:1315461 6480464 perfluorooctanoic acid results in increased expression of PLTP mRNA CTD PMID:17681415 , PMID:30657992 phenobarbital multiple interactions ISO RGD:1315461 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of PLTP mRNA] CTD PMID:19482888 phenobarbital decreases expression ISO RGD:1315461 6480464 Phenobarbital results in decreased expression of PLTP mRNA CTD PMID:19270015 , PMID:23091169 phenobarbital increases expression ISO RGD:1315461 6480464 Phenobarbital results in increased expression of PLTP mRNA CTD PMID:19482888 phenytoin increases expression ISO RGD:1315461 6480464 Phenytoin results in increased expression of PLTP mRNA CTD PMID:15136057 phosgene affects expression ISO RGD:1315461 6480464 Phosgene affects the expression of PLTP mRNA CTD PMID:16300373 pirinixic acid multiple interactions ISO RGD:1315461 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of PLTP mRNA] CTD PMID:20059764 pirinixic acid increases expression ISO RGD:1315461 6480464 pirinixic acid results in increased expression of PLTP mRNA CTD PMID:11798191 more ... propiconazole decreases expression ISO RGD:1315461 6480464 propiconazole results in decreased expression of PLTP mRNA CTD PMID:21278054 quercetin increases expression ISO RGD:1315460 6480464 Quercetin results in increased expression of PLTP mRNA CTD PMID:21632981 rotenone increases expression EXP 6480464 Rotenone results in increased expression of PLTP mRNA CTD PMID:28374803 sarin decreases expression ISO RGD:1315460 6480464 Sarin results in decreased expression of PLTP mRNA CTD PMID:19522546 SB 431542 multiple interactions ISO RGD:1315460 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLTP mRNA CTD PMID:27188386 silver atom decreases expression ISO RGD:1315461 6480464 Silver results in decreased expression of PLTP mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1315461 6480464 Silver results in decreased expression of PLTP mRNA CTD PMID:27131904 sodium arsenate decreases expression ISO RGD:1315461 6480464 sodium arsenate results in decreased expression of PLTP mRNA CTD PMID:21795629 sodium arsenite decreases expression ISO RGD:1315461 6480464 sodium arsenite results in decreased expression of PLTP mRNA CTD PMID:21512104 sunitinib increases expression ISO RGD:1315460 6480464 Sunitinib results in increased expression of PLTP mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1315461 6480464 Tamoxifen affects the expression of PLTP mRNA CTD PMID:17555576 temozolomide decreases expression ISO RGD:1315460 6480464 Temozolomide results in decreased expression of PLTP mRNA CTD PMID:31758290 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLTP mRNA CTD PMID:32741896 tetrachloromethane affects expression ISO RGD:1315461 6480464 Carbon Tetrachloride affects the expression of PLTP mRNA CTD PMID:17484886 thalidomide decreases expression ISO RGD:1315461 6480464 Thalidomide results in decreased expression of PLTP mRNA CTD PMID:26217789 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PLTP mRNA CTD PMID:26222700 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of PLTP mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:1315461 6480464 titanium dioxide results in decreased expression of PLTP mRNA CTD PMID:23557971 , PMID:27760801 titanium dioxide increases expression ISO RGD:1315461 6480464 titanium dioxide results in increased expression of PLTP mRNA CTD PMID:29264374 trichloroethene increases expression ISO RGD:1315461 6480464 Trichloroethylene results in increased expression of PLTP mRNA CTD PMID:25549359 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of PLTP mRNA CTD PMID:33387578 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of PLTP mRNA CTD PMID:30589522 troglitazone increases expression ISO RGD:1315461 6480464 troglitazone results in increased expression of PLTP mRNA CTD PMID:28973697 valproic acid affects expression ISO RGD:1315461 6480464 Valproic Acid affects the expression of PLTP mRNA CTD PMID:17292431 valproic acid increases expression ISO RGD:1315461 6480464 Valproic Acid results in increased expression of PLTP mRNA CTD PMID:24535564 valproic acid affects expression ISO RGD:1315460 6480464 Valproic Acid affects the expression of PLTP mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1315460 6480464 Valproic Acid results in increased expression of PLTP mRNA CTD PMID:23179753 more ...